Avectas
Lisa O'Flynn is currently the VP of Process & Analytical Development at Avectas. Previously, Lisa held positions as the Head of Process Development at Orbsen Therapeutics Limited and as a PhD Researcher at REMEDI NCBES NUI Galway. Lisa also has a Master of Science in Immunology from Imperial College London. Throughout their career, Lisa has focused on cell therapies and process optimization.
This person is not in any offices
Avectas
1 followers
Avectas is a cell engineering business focused on improving the cost, manufacturing, and patient outcomes for the next generation of cellular therapies. Avectas is developing a unique delivery technology platform, Solupore®, to enable the ex-vivo manufacture of gene-modified cell therapy products, with partners.